The role of Elastin degradation in the pathogenes of liver fibrosis

Medicine & Life Sciences

1. Liver Cirrhosis 100%
2. Fibrosis 94%
3. Liver 78%
4. Myofibroblasts 77%
5. Macrophages 59%
6. Endoderm 39%
7. Hepatocytes 35%
8. Stem Cells 33%
9. Galectin 3 33%
10. Hepatic Stellate Cells 31%
11. Human Embryonic Stem Cells 30%
12. Matrix Metalloproteinases 26%
13. Regeneration 21%
14. Bone Marrow 21%
15. Choline Deficiency 21%
16. Rodent Diseases 20%
17. Liver Diseases 20%
18. Apoptosis 20%
19. Matrix Metalloproteinase 12 19%
20. Relaxin 17%
21. Hepatitis E 17%
22. Wounds and Injuries 16%
23. Fontan Procedure 16%
24. Nerve Growth Factor Receptor 16%
25. Bone Marrow Cells 15%
26. Pericytes 15%
27. Idiopathic Pulmonary Fibrosis 15%
28. Extracellular Matrix 14%
29. Elastin 14%
30. Induced Pluripotent Stem Cells 14%
31. Portal Hypertension 13%
32. Matrix Metalloproteinase 2 13%
33. Cadherins 13%
34. Mesoderm 13%
35. Fatty Liver 13%
36. Methionine 13%
37. Stromal Cells 12%
38. Metabolic Networks and Pathways 12%
39. Monocytes 12%
40. Choline 12%
41. Cicatrix 12%
42. Nerve Growth Factor 11%
43. Inflammation 11%
44. Rodentia 11%
45. Hepatocellular Carcinoma 11%
46. Biochemistry 11%
47. In Vitro Techniques 11%
48. Cell Differentiation 10%
49. Fatty Acids 10%
50. Phenotype 10%
51. Cell- and Tissue-Based Therapy 10%
52. Anti-Inflammatory Agents 10%
53. Adrenal Cortex Hormones 10%
54. Chronic Disease 9%
55. Diet 9%
56. Animal Models 9%
57. Therapeutics 8%
58. Wound Healing 8%
59. Injections 7%
60. Transforming Growth Factor beta 7%
61. Hepatic Veins 7%
62. relaxin receptors 7%
63. Kidney 6%
64. Lung 6%
65. Incidence 6%
66. mouse matrix metallopeptidase 12 5%
67. Cell Culture Techniques 5%
68. Developed Countries 5%
69. Ligands 5%